Meng Lan
Impact in
-
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
-
- Cancer Immunotherapy and Biomarkers
Papers in ⓘ
-
- Flavonoids in Medical Research 4
- Co-authors
- Tengteng Zou (11 shared papers)Tiange Cai (12 shared papers)Yu Cai (12 shared papers)Lihong Li (3 shared papers)Zhen Chen (1 shared paper)Rui Yu (1 shared paper)Qi Wang (1 shared paper)Fengjie Liu (11 shared papers)
In The Last Decade
Meng Lan
14 papers receiving 535 citations
Peers
Comparison fields: 5 of 89
- Immunology 150
- Oncology 173
- Biomaterials 81
- Toxicology 17
- Cancer Research 67
Countries citing papers authored by Meng Lan
This map shows the geographic impact of Meng Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Lan more than expected).
Fields of papers citing papers by Meng Lan
This network shows the impact of papers produced by Meng Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Lan. The network helps show where Meng Lan may publish in the future.
Co-authors
The 25 scholars most cited alongside Meng Lan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 266 | |
| 2 | 2021 | 37 | |
| 3 | 2019 | 36 | |
| 4 | 2022 | 33 | |
| 5 | 2021 | 28 | |
| 6 | 2019 | 27 | |
| 7 | 2021 | 23 | |
| 8 | 2021 | 22 | |
| 9 | 2021 | 15 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 11 | |
| 13 | 2021 | 10 | |
| 14 | 2024 | 8 |
About Meng Lan
Meng Lan is a scholar working on Toxicology, Pharmacology, Biomaterials, Molecular Medicine and Cancer Research, having authored 14 papers that have together received 541 indexed citations. Recurring topics across this work include Flavonoids in Medical Research (4 papers), Nanoplatforms for cancer theranostics (3 papers), Biological Activity of Diterpenoids and Biflavonoids (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers), Immune cells in cancer (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Immunology (150 citations), Oncology (173 citations), Biomaterials (81 citations), Toxicology (17 citations) and Cancer Research (67 citations). Meng Lan has collaborated with scholars based in China, Russia and Thailand. Frequent co-authors include Tengteng Zou, Tiange Cai, Yu Cai, Lihong Li, Zhen Chen, Rui Yu, Qi Wang, Fengjie Liu, Hui Zhang and Lihong Li. Their work appears in journals such as Cancer Nanotechnology, European Journal of Pharmaceutics and Biopharmaceutics, Journal of Pharmaceutical Sciences, Nanomedicine and Chemistry & Biodiversity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.